Congratulations to all the Nova Scotia start-ups selected to participate in our 2017 ocean technology and clean technology acceleration initiatives.
Innovacorp announced the appointment of two new members to its board of directors today, Nov. 9.
The new appointments are David Wilson, president of Wilsons Security, and Dawn Umlah, chief operating officer of Spring Loaded Technology.
Appili Therapeutics Inc. (Appili), an anti-infective drug development company, announced today it has been awarded a $1.2 million USD grant by the Department of Defense, Congressionally Directed Medical Research Programs, Peer Reviewed Medical Research Program.
A new wearable technology company in Halifax is receiving $50,000 in funding and business guidance through Innovacorp’s Spark Innovation Challenge. The business, Axem Neurotechnology, is one of four winners selected in the Spark Halifax region of the province.
The winners of our 2017 Spark Innovation Challenge are described below.
Appili Therapeutics Inc. (the “Company” or “Appili”), an anti-infective drug development company, announced today that both the US Food and Drug Administration (FDA) and Health Canada have cleared its IND and CTA clinical investigation applications, respectively, to conduct a clinical trial of ATI-1501, a taste-masked antibiotic targeting anaerobic bacteria like Clostridium difficile.
Appili Therapeutics Inc. (the “Company” or “Appili”), an anti-infective drug development company, announced today it raised $3,062,000 in a private placement financing, bringing the total equity raised since its seed round in March 2016 to $7,477,000.
Volta Labs is launching a new program, Volta Cohort, designed to help early stage, high calibre founders attract and secure venture capital sooner.
Judges gathered in the four Spark competition regions this week to review the 136 Spark submissions. The judging committees in each region selected a shortlist of applicants to move on in the competition.